Skip to main content
. 2016 Nov 24;8(6):10620–10627. doi: 10.18632/oncotarget.13538

Table 4. ORs for the comparison of cutoff points between cancer and benign groups.

BPER Breast cancer Benign lesions OR (95% CI) P
Pr-menopausal (N=47) 0.03
<51.4% 26(55) 36(77) 1.0
≥51.4% 21(45) 11(23) 2.6 (1.1, 6.4)
Postmenopausal (N=54) 0.011
<13.3% 16(30) 29(54) 1.0
≥13.3% 38(70) 25(46) 2.8 (1.2, 6.1)

BPER, background parenchymal enhancement rate; CI, confidence interval; OR, odds ratio